These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 39225838)

  • 1. Letter to the editor: comparative efficacy and safety of clindamycin phosphate/benzoyl peroxide and adapalene/benzoyl peroxide in acne treatment: a systematic review and meta-analysis of randomized controlled trials.
    Sesgundo JA; Borra UR; Teslim AA; Hikal H; Qammar A; Adams D; Serag I
    Arch Dermatol Res; 2024 Sep; 316(8):595. PubMed ID: 39225838
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy and Safety of a Fixed-Dose Clindamycin Phosphate 1.2%, Benzoyl Peroxide 3.1%, and Adapalene 0.15% Gel for Moderate-to-Severe Acne: A Randomized Phase II Study of the First Triple-Combination Drug.
    Stein Gold L; Baldwin H; Kircik LH; Weiss JS; Pariser DM; Callender V; Lain E; Gold M; Beer K; Draelos Z; Sadick N; Pillai R; Bhatt V; Tanghetti EA
    Am J Clin Dermatol; 2022 Jan; 23(1):93-104. PubMed ID: 34674160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fixed-combination monotherapy with clindamycin 1%- benzoyl peroxide 5% gel: focus on acne patient benefits and clinical use. Introduction.
    Eichenfield L
    Cutis; 2009 Nov; 84(5 Suppl):3-4. PubMed ID: 19999186
    [No Abstract]   [Full Text] [Related]  

  • 4. Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel for Male and Female Acne: Phase 3 Analysis.
    Lain ET; Bhatia N; Kircik L; Gold LS; Harper JC; Bunick CG; Guenin E; Baldwin H; Feldman SR; Rosso JQD
    J Drugs Dermatol; 2024 Oct; 23(10):873-881. PubMed ID: 39361705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The tolerability profile of clindamycin 1%/benzoyl peroxide 5% gel vs. adapalene 0.1%/benzoyl peroxide 2.5% gel for facial acne: results of a randomized, single-blind, split-face study.
    Gonzalez P; Vila R; Cirigliano M
    J Cosmet Dermatol; 2012 Dec; 11(4):251-60. PubMed ID: 23174047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clindamycin phosphate 1·2%-benzoyl peroxide 3·0% fixed-dose combination gel has an effective and acceptable safety and tolerability profile for the treatment of acne vulgaris in Japanese patients: a phase III, multicentre, randomised, single-blinded, active-controlled, parallel-group study.
    Kawashima M; Hashimoto H; Alió Sáenz AB; Ono M; Yamada M
    Br J Dermatol; 2015 Feb; 172(2):494-503. PubMed ID: 25040180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meta-analysis of randomized controlled trials using 5% benzoyl peroxide and clindamycin versus 2.5% benzoyl peroxide and clindamycin topical treatments in acne.
    Seidler EM; Kimball AB
    J Am Acad Dermatol; 2011 Oct; 65(4):e117-e119. PubMed ID: 21816505
    [No Abstract]   [Full Text] [Related]  

  • 8. Cumulative irritancy comparison of topical retinoid and antimicrobial combination therapies.
    Dosik JS; Gilbert RD; Arsonnaud S
    Skinmed; 2006; 5(5):219-23. PubMed ID: 16957432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benzoyl peroxide: enhancing antibiotic efficacy in acne management.
    Dutil M
    Skin Therapy Lett; 2010; 15(10):5-7. PubMed ID: 21076800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adapalene 0.1%/benzoyl peroxide 2.5% gel: a review of its use in the treatment of acne vulgaris in patients aged ≥ 12 years.
    Keating GM
    Am J Clin Dermatol; 2011 Dec; 12(6):407-20. PubMed ID: 21967116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Moderate and Severe Inflammatory Acne Vulgaris Effectively Treated with Single-Agent Therapy by a New Fixed-Dose Combination Adapalene 0.3 %/Benzoyl Peroxide 2.5 % Gel: A Randomized, Double-Blind, Parallel-Group, Controlled Study.
    Stein Gold L; Weiss J; Rueda MJ; Liu H; Tanghetti E
    Am J Clin Dermatol; 2016 Jun; 17(3):293-303. PubMed ID: 26945741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triple-Combination Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel for Acne in Adult and Pediatric Participants.
    Baldwin H; Gold LS; Harper JC; Alexis AF; Callender VD; Kircik L; Guenin E; Eichenfield LF
    J Drugs Dermatol; 2024 Jun; 23(6):394-402. PubMed ID: 38834226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized tolerability analysis of clindamycin phosphate 1.2%-tretinoin 0.025% gel used with benzoyl peroxide wash 4% for acne vulgaris.
    Draelos ZD; Potts A; Alió Saenz AB;
    Cutis; 2010 Dec; 86(6):310-8. PubMed ID: 21284283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study results of benzoyl peroxide 5%/clindamycin 1% topical gel, adapalene 0.1% gel, and use in combination for acne vulgaris.
    Del Rosso JQ
    J Drugs Dermatol; 2007 Jun; 6(6):616-22. PubMed ID: 17668527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fixed-combination clindamycin 1%-benzoyl peroxide 5% hydrating gel: a flexible component of acne management.
    Tanghetti E
    Cutis; 2009 Nov; 84(5 Suppl):18-24. PubMed ID: 19999189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic exposure to benzoic acid and hippuric acid following topical application of clindamycin 1%/benzoyl peroxide 3% fixed-dose combination gel in Japanese patients with acne vulgaris.
    Ino H; Takahashi N; Saenz AA; Wakamatsu A; Hashimoto H; Nakahara N; Hasegawa S
    Clin Pharmacol Drug Dev; 2015 Jan; 4(1):18-24. PubMed ID: 27128000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of moderate to severe acne vulgaris in a Hispanic population: a post-hoc analysis of efficacy and tolerability of clindamycin phosphate 1.2%/benzoyl peroxide 2.5% gel.
    Cook-Bolden FE
    J Drugs Dermatol; 2012 Apr; 11(4):455-9. PubMed ID: 22453581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fitzpatrick skin types and clindamycin phosphate 1.2%/benzoyl peroxide gel: efficacy and tolerability of treatment in moderate to severe acne.
    Callender VD
    J Drugs Dermatol; 2012 May; 11(5):643-8. PubMed ID: 22527435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and tolerability of a fixed combination of clindamycin phosphate (1.2%) and low concentration benzoyl peroxide (2.5%) aqueous gel in moderate or severe acne subpopulations.
    Webster G; Rich P; Gold MH; Mraz S; Calvarese B; Chen D
    J Drugs Dermatol; 2009 Aug; 8(8):736-43. PubMed ID: 19663111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Customized Single-agent Therapy Management of Severe Inflammatory Acne: A Randomized, Double-blind, Parallel-group, Controlled Study of a New Treatment--Adapalene 0.3%-Benzoyl Peroxide 2.5% Gel.
    Weiss J; Stein Gold L; Leoni M; Rueda MJ; Liu H; Tanghetti E
    J Drugs Dermatol; 2015 Dec; 14(12):1427-35. PubMed ID: 26659936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.